InsidersTradesSigma
Track the 에스티팜 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 에스티팜 has recorded 8 public disclosures. Market capitalisation: €1,965.1bn. The latest transaction was filed on 30 April 2026 (Purchase). Among the most active insiders: 동아쏘시오홀딩스. Every trade is free.
8
Insider Decl.
n/a
Thresholds
€20m
5 ops.
Buy Volume
€577,438
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 에스티팜 Strong Buy (bullish), based on 10 analysts. Average price target: ₩180,000.
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,106 of 29,057 companies
51.0
score / 100
Value32
Quality70
FCF yld-1.4%
Earn yld2.4%
EV/EBITDA25.7x
ROE·
Gross mgn41%
Net mgn17%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 April 2026
Declarations8 total
8 of 8 declarations
Acerca de 에스티팜
Cotizada en el mercado XKRX, 에스티팜 es una empresa del sector de la salud y farmacéutico. Se centra en el desarrollo y la producción de medicamentos innovadores.